Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. MU
5. META
6. SPY
7. ACN
8. BLZE
9. IBM
10. NKE

Go back to Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
ARISTOTLE (NASDAQ: ARTL) Delayed: 1.26 --0 (-0%)
Previous Close $1.26    52 Week High $6.22 
Open $1.26    52 Week Low $2.74 
Day High $1.26    P/E N/A 
Day Low $1.26    EPS $-0.21 
Volume 4,533